Literature DB >> 13091327

Studies on immunity to streptococcal infections in man.

L W WANNAMAKER, F W DENNY, W D PERRY, A C SIEGEL, C H RAMMELKAMP.   

Abstract

Entities:  

Keywords:  STREPTOCOCCAL INFECTIONS/immunology

Mesh：

Year:  1953        PMID： 13091327

Source DB:  PubMed          Journal:  AMA Am J Dis Child        ISSN： 2374-2941


× No keyword cloud information.
  21 in total

1.  Type-specific streptococcal antibody.

Authors:  F W DENNY; W D PERRY; L W WANNAMAKER
Journal:  J Clin Invest       Date:  1957-07       Impact factor: 14.808

2.  Recall of type specific antibodies in man by injections of streptococcal cell walls.

Authors:  E V POTTER; G H STOLLERMAN; A C SIEGEL
Journal:  J Clin Invest       Date:  1962-02       Impact factor: 14.808

3.  Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.

Authors:  Dace V Madore; Bruce D Meade; Fran Rubin; Carolyn Deal; Freyja Lynn
Journal:  Vaccine       Date:  2010-05-12       Impact factor: 3.641

4.  Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes.

Authors:  Thomas A Penfound; Edna Y Chiang; Elwaleed A Ahmed; James B Dale
Journal:  Vaccine       Date:  2010-05-21       Impact factor: 3.641

5.  A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.

Authors:  Martina Sanderson-Smith; David M P De Oliveira; Julien Guglielmini; David J McMillan; Therese Vu; Jessica K Holien; Anna Henningham; Andrew C Steer; Debra E Bessen; James B Dale; Nigel Curtis; Bernard W Beall; Mark J Walker; Michael W Parker; Jonathan R Carapetis; Laurence Van Melderen; Kadaba S Sriprakash; Pierre R Smeesters
Journal:  J Infect Dis       Date:  2014-05-05       Impact factor: 5.226

6.  Murine model of recurrent group G streptococcal cellulitis: no evidence of protective immunity.

Authors:  A L Bisno; J M Gaviria
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

7.  A novel live vector group A streptococcal emm type 9 vaccine delivered intranasally protects mice against challenge infection with emm type 9 group A streptococci.

Authors:  Aniela Wozniak; Patricia García; Enrique A Geoffroy; Daniel B Aguirre; Samantha A González; Victoria A Sarno; James B Dale; Francisco J Salazar-Echegarai; Andrea Vera; Susan M Bueno; Alexis M Kalergis
Journal:  Clin Vaccine Immunol       Date:  2014-07-23

8.  Naturally Acquired Protection Against Upper Respiratory Symptoms Involving Group A Streptococcus in a Longitudinal Cohort Study.

Authors:  Joseph A Lewnard; Lilith K Whittles; Anne-Marie Rick; Judith M Martin
Journal:  Clin Infect Dis       Date:  2020-11-05       Impact factor: 9.079

9.  Group A beta-hemolytic streptococcal bacteremia in a patient with sickle cell anemia on penicillin prophylaxis.

Authors:  W LeBlanc; H Salah; Y Khakoo
Journal:  J Natl Med Assoc       Date:  1995-05       Impact factor: 1.798

10.  The dynamic nature of group A streptococcal epidemiology in tropical communities with high rates of rheumatic heart disease.

Authors:  M I McDonald; R J Towers; R Andrews; N Benger; P Fagan; B J Currie; J R Carapetis
Journal:  Epidemiol Infect       Date:  2007-05-31       Impact factor: 2.451
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.